The use of point of care coagulometers in clinical trials

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

20 Citationer (Scopus)
OriginalsprogEngelsk
Artikelnummeri575
TidsskriftB M J
Vol/bind352
ISSN0959-8146
StatusUdgivet - 2016

Citer dette

@article{c039eab20e22418ea2d84d9fc9a7a5b3,
title = "The use of point of care coagulometers in clinical trials",
author = "Nielsen, {Peter Br{\o}nnum} and Christensen, {Thomas Decker} and Larsen, {Torben Bjerregaard}",
note = "Response to: Rivaroxaban: can we trust the evidence? BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i575 (Published 03 February 2016)",
year = "2016",
language = "English",
volume = "352",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Group",

}

The use of point of care coagulometers in clinical trials. / Nielsen, Peter Brønnum; Christensen, Thomas Decker; Larsen, Torben Bjerregaard.

I: B M J, Bind 352, i575, 2016.

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

TY - JOUR

T1 - The use of point of care coagulometers in clinical trials

AU - Nielsen, Peter Brønnum

AU - Christensen, Thomas Decker

AU - Larsen, Torben Bjerregaard

N1 - Response to: Rivaroxaban: can we trust the evidence? BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i575 (Published 03 February 2016)

PY - 2016

Y1 - 2016

M3 - Comment/debate

VL - 352

JO - The BMJ

JF - The BMJ

SN - 0959-8146

M1 - i575

ER -